Total Payments
$88,982
2024 Payments
$1,933
Companies
35
Transactions
687
Medicare Patients
1,326
Medicare Billing
$276,034
Payment Breakdown by Category
Other$65,535 (73.7%)
Food & Beverage$13,009 (14.6%)
Travel$5,514 (6.2%)
Consulting$4,698 (5.3%)
Education$225.53 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65,535 | 42 | 73.7% |
| Food and Beverage | $13,009 | 610 | 14.6% |
| Travel and Lodging | $5,514 | 25 | 6.2% |
| Consulting Fee | $4,698 | 1 | 5.3% |
| Education | $225.53 | 9 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $22,872 | 60 | $0 (2020) |
| ABBVIE INC. | $18,479 | 100 | $0 (2024) |
| Alkermes, Inc. | $18,352 | 74 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $11,731 | 39 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $5,621 | 9 | $0 (2023) |
| ITI, Inc. | $2,834 | 18 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,937 | 79 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $1,318 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $923.82 | 49 | $0 (2024) |
| Lundbeck LLC | $558.53 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,933 | 90 | ABBVIE INC. ($451.83) |
| 2023 | $32,187 | 138 | Alkermes, Inc. ($17,624) |
| 2022 | $6,480 | 108 | ABBVIE INC. ($4,850) |
| 2021 | $21,118 | 124 | Supernus Pharmaceuticals, Inc. ($11,495) |
| 2020 | $3,346 | 45 | Allergan, Inc. ($2,622) |
| 2019 | $9,351 | 91 | Allergan Inc. ($8,119) |
| 2018 | $8,842 | 53 | Allergan Inc. ($8,261) |
| 2017 | $5,725 | 38 | Allergan Inc. ($3,869) |
All Payment Transactions
687 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: CNS | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: CNS | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: CNS | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CNS | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Neurology | ||||||
| 09/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 292 | 1,116 | $142,285 | $68,473 |
| 2022 | 5 | 339 | 1,221 | $149,925 | $71,603 |
| 2021 | 6 | 330 | 1,236 | $133,035 | $71,122 |
| 2020 | 6 | 365 | 1,213 | $150,565 | $64,836 |
Total Patients
1,326
Total Services
4,786
Medicare Billing
$276,034
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 528 | $61,425 | $35,260 | 57.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 214 | $32,100 | $12,966 | 40.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 44 | 284 | $28,400 | $10,625 | 37.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 29 | 29 | $10,150 | $3,724 | 36.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 22 | 22 | $4,550 | $3,081 | 67.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 19 | $2,660 | $1,581 | 59.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $3,000 | $1,237 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 602 | $64,425 | $40,905 | 63.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 198 | $29,700 | $10,442 | 35.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 62 | 318 | $31,800 | $9,375 | 29.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 36 | 37 | $12,950 | $5,079 | 39.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 23 | 23 | $4,600 | $3,549 | 77.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 42 | 43 | $6,450 | $2,253 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 640 | $53,375 | $39,485 | 74.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 203 | $30,450 | $11,356 | 37.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 46 | 269 | $26,900 | $8,086 | 30.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 40 | 42 | $10,920 | $5,859 | 53.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 21 | 21 | $3,675 | $2,652 | 72.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 34 | 35 | $5,250 | $1,941 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 26 | $2,465 | $1,742 | 70.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 72 | 401 | $60,150 | $22,857 | 38.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 214 | $17,935 | $12,594 | 70.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 66 | 391 | $39,100 | $12,086 | 30.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 50 | 53 | $13,780 | $5,950 | 43.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 82 | $8,170 | $5,585 | 68.4% |
About Dr. Ramesh Eluri, M.D
Dr. Ramesh Eluri, M.D is a Psychiatry healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497706097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Eluri, M.D has received a total of $88,982 in payments from pharmaceutical and medical device companies, with $1,933 received in 2024. These payments were reported across 687 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($65,535).
As a Medicare-enrolled provider, Eluri has provided services to 1,326 Medicare beneficiaries, totaling 4,786 services with total Medicare billing of $276,034. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Philadelphia, PA
- Active Since 05/16/2006
- Last Updated 11/12/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1497706097
Products in Payments
- VRAYLAR (Drug) $41,343
- ARISTADA (Drug) $18,143
- QELBREE (Drug) $9,684
- CAPLYTA (Drug) $2,868
- REXULTI (Drug) $1,705
- NUEDEXTA (Drug) $1,325
- INVEGA SUSTENNA (Drug) $768.54
- ABILIFY MAINTENA (Drug) $525.93
- TRINTELLIX (Drug) $473.70
- Auvelity (Drug) $423.29
- HETLIOZ (Drug) $405.95
- INGREZZA (Drug) $402.27
- Adzenys XR-ODT (Drug) $336.50
- LATUDA (Drug) $241.20
- AUSTEDO (Drug) $210.18
- PERSERIS (Drug) $190.14
- SPRAVATO (Drug) $155.28
- VYVANSE (Drug) $149.17
- SUNOSI (Drug) $147.29
- BRINTELLIX (Drug) $132.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Philadelphia
Daniel Weintraub, Md, MD
Psychiatry — Payments: $614,211
Psychiatry $614,211
Dr. Michael Thase, Md, MD
Psychiatry — Payments: $418,426
Psychiatry $418,426
Dr. Karl Doghramji, Md, MD
Psychiatry — Payments: $130,409
Psychiatry $130,409
Richard Jaffe, Md, MD
Psychiatry — Payments: $126,747
Psychiatry $126,747
Kyle Kampman, Md, MD
Psychiatry — Payments: $118,739
Psychiatry $118,739
John Lauriello, Md, MD
Psychiatry — Payments: $75,274
Psychiatry $75,274